A randomised, double-blind, placebo-controlled, multi-institutional phase II study of adjuvant anti-PD-1 in patients with stage I-III Merkel cell carcinoma [I-MAT study]

Wen Xu, Michael Poulsen, Victoria Atkinson, Gerald Fogarty, Michael Veness, Bernard Smithers, David Gyorki, Victoria Mar, Julie Howle, Alexander Guminski, Narelle Williams, Elizabeth Paton